The DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.
A meta-analysis of the efficacy of over-the-counter nicotine replacement
Open accessAbstract
OBJECTIVE: To determine whether over-the-counter (OTC) nicotine replacement therapy (NRT) is pharmacologically efficacious, whether it produces abstinence rates similar to those in prescription settings, and to estimate the long term (that is, greater than six month) abstinence rate with OTC NRT. METHOD: Systematic literature review. DATA SOURCES: Medline, Psych Abstracts, bibliographies, requests of scientists. STUDY SELECTION: Studies comparing OTC NRT versus OTC placebo or studies comparing OTC NRT versus prescription NRT that reported abstinence rates and for which a full study report was available. DATA EXTRACTION: Two of the authors independently reviewed studies and compared results. DATA SYNTHESIS: Meta-analysis was performed by first testing for homogeneity across studies, then combining odds ratios (ORs) weighting by inverse variance and proportions weighting by study sample size. RESULTS: One OTC NRT versus OTC placebo nicotine gum study was excluded due to small sample size and different setting. The four remaining studies were randomised trials of nicotine versus placebo patch with ORs of 2.1-3.2. These outcomes were homogenous and when combined resulted in an OR favouring NRT of 2.5 (95% confidence interval (CI) 1.8 to 3.6). Among the two randomised and two non-randomised trials of OTC NRT versus prescription NRT, one small study had an OR of 0.3, two others had ORs of 1.0 and 1.4, and a fourth study had an OR of 3.6. These results were not homogenous; however, when combined via a random effects model the estimated OR was not less than 1.0--that is, OR 1.4 (95% CI 0.6 to 3.3). The long term (that is, greater than six months) quit rates for OTC NRT was 1% and 6% in two studies and 8-11% in five other studies. These results were not homogenous; however, when combined the estimated OR was 7% (95% CI 4% to 11%). CONCLUSIONS: OTC NRT is pharmacologically efficacious and produces modest quit rates similar to that seen in real world prescription practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Bupropion is thought to target the neurochemistry of nicotine addiction by blocking the reuptake of dopamine and noradrenaline and therefore increasing their levels in the synapse.”
From Tobacco addiction (2008) · cites this paper as [96]
In the citing paper
“It is also considered to function as a noncompetitive nicotinic AChR antagonist (96).”
From Tobacco addiction (2008) · cites this paper as [96]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
The Handbook of Research Synthesis.
Howel, D., Cooper, H., & Hedges, L. V. (1995) · Biometrics · doi:10.2307/2533295 · Cited by 3,657
Treating tobacco use and dependence-Clinical practice guideline
Mc, F. (2000) · Medical Entomology and Zoology · Cited by 3,616
Treating Tobacco Use and Dependence
(2008) · PEDIATRICS · doi:10.1542/peds.2008-1627 · Cited by 2,701
Biochemical verification of tobacco use and cessation
Benowitz, N. L., III, P. J., Ahijevych, K., Jarvis, M. J., Hall, S., LeHouezec, J., Hansson, A., Lichtenstein, E., Henningfield, J., Tsoh, J., et al. (2002) · Nicotine & Tobacco Research · doi:10.1080/14622200210123581 · Cited by 1,800
Assessing outcome in smoking cessation studies.
Velicer, W. F., Prochaska, J. O., Rossi, J. S., & Snow, M. G. (1992) · Psychological Bulletin · doi:10.1037/0033-2909.111.1.23 · Cited by 833
Treating Tobacco Use and Dependence
Goolsby, M. J. (2001) · Journal of the American Academy of Nurse Practitioners · doi:10.1111/j.1745-7599.2001.tb00227.x · Cited by 718
National Patterns in the Treatment of Smokers by Physicians
Thorndike, A. N. (1998) · JAMA · doi:10.1001/jama.279.8.604 · Cited by 384
Recent Advances in the Pharmacotherapy of Smoking
Hughes, J. R. (1999) · JAMA · doi:10.1001/jama.281.1.72 · Cited by 380
Self-citationCohen, S., Lichtenstein, E., Prochaska, J. O., Rossi, J. S., Gritz, E. R., Carr, C. R., Orleans, C. T., Schoenbach, V. J., Biener, L., Abrams, D. B., et al. (1989) · American Psychologist · doi:10.1037//0003-066x.44.11.1355 · Cited by 344
Flagged first, then by citations
2 of the 53 references couldn’t be matched to a known paper.
Research works printed but not linked: 14
- Silagy C, Mant D, Fowler G, et al. Nicotine replacement therapy for smoking cessation (Cochrane Review). Oxford: Update Software, The Cochrane Library, Issue 5, 2000.
- 1992, J Family Practice, 34, 739
- 1997, MMWR Morb Mortal Wkly Rep, 46, 867
- 2002, Am J Public Health, 19, 437
- 2000, MMWR Morb Mortal Wkly Rep, 49, 665
- 2001, Drug and Alcohol Review, 20, 319, 10.1080/09595230120079639 · DOI
- 1991, Ann Pharmacother, 25, 730
- 1992, J Family Practice, 34, 61
- 1999, Br J General Practice, 49, 127
- 2001, Nicotine and Tobacco Research, 3, 272
- 2001, MMWR Morb Mortal Wkly Rep, 50, 979
- 1997, Clin Pharmacol Therapeutics, 61, 191
- Hughes JR. The evidence for hardening. Is the target hardening? NCI Smoking and Tobacco Control Monograph. Rockville, Maryland: National Cancer Institute (in press).
- Hughes JR, Burns DM. Impact of medications on smoking cessation. In: Population based smoking cessation: proceedings of a conference on what works to influence cessation in the general population. Smoking and Tobacco Control Monograph No. 12. Bethesda, Maryland: National Cancer Institute, 2001:155–64
Cited by
Sorted by citations
Items 101–200 of 204
Nicotine reinforcement in never-smokers
Duke, A. N., Johnson, M. W., Reissig, C. J., & Griffiths, R. R. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4053-4 · Cited by 25
Psychooncology: the state of its development in 2006
Levin, T. T., & Kissane, D. W. (2006) · The European Journal of Psychiatry · doi:10.4321/s0213-61632006000300006 · Cited by 23
Janes, A. C., Jensen, J. E., Farmer, S. L., Frederick, B. B., Pizzagalli, D. A., & Lukas, S. E. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.10 · Cited by 25
Velicer, W. F., Keller, S., Friedman, R. H., Fava, J. L., Gulliver, S. B., Ward, R. M., Ramelson, H. Z., Prochaska, J. O., & Cottrill, S. D. (2005) · Annals of Behavioral Medicine · doi:10.1207/s15324796abm2903_4 · Cited by 25
Comparison of three nicotine treatments: initial reactions and preferences with guided use
Schneider, N. G., Terrace, S. M., Koury, M. A., Patel, S., Vaghaiwalla, B., Pendergrass, R., Olmstead, R. E., & Cortner, C. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0123-3 · Cited by 25
Acute baclofen diminishes resting baseline blood flow to limbic structures: A perfusion fMRI study
Franklin, T. R., Shin, J., Jagannathan, K., Suh, J. J., Detre, J. A., O’Brien, C. P., & Childress, A. R. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.03.016 · Cited by 25
Etter, J., Laszlo, E., & Perneger, T. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000115666.45074.d6 · Cited by 23
Smith, A. E., Cavallo, D. A., McFetridge, A. K., Liss, T. B., & Krishnan‐Sarin, S. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802219357 · Cited by 24
Sales, M. P. U., de Figueiredo, M. R. F., Oliveira, M. I., & de Castro, H. N. (2006) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132006000500007 · Cited by 24
Kim, Y., & Cho, W. (2014) · PubMed Central · Cited by 23
Smoking Cessation Pharmacotherapy, Even Without Counseling, Remains a Cornerstone of Treatment
Tindle, H. A., & Greevy, R. A. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx246 · Cited by 15
Seven Year Follow-up of Smoking Cessation with Smokeless Tobacco
Tilashalski, K. R., Rodu, B., & Cole, P. T. (2005) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2005.10399753 · Cited by 22
de Viron, S., Malats, N., der Heyden, J. V., Oyen, H. J. V., & Brand, A. M. (2013) · Public Health Genomics · doi:10.1159/000351453 · Cited by 21
Chen, B., Silvestri, G. A., Dahne, J., Lee, K., & Carpenter, M. J. (2022) · Journal of General Internal Medicine · doi:10.1007/s11606-021-07335-x · Cited by 21
Smoking in Italy 2003, with a Focus on the Young
Gallus, S., Pacifici, R., Colombo, P., Scarpino, V., Zuccaro, P., Bosetti, C., Apolone, G., & Vecchia, C. L. (2004) · Tumori Journal · doi:10.1177/030089160409000202 · Cited by 21
Over-the-counter nicotine replacement therapy: Can its impact on smoking cessation be enhanced?
Amodei, N., & Lamb, R. J. (2008) · Psychology of Addictive Behaviors · doi:10.1037/0893-164x.22.4.472 · Cited by 20
Stoker, A. K., & Markou, A. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13482-6_5 · Cited by 22
Nelson, P. R., Chen, P., Battista, D. R., Pillitteri, J. L., & Shiffman, S. M. (2018) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty011 · Cited by 20
Self-citationSmoking Treatment: A Report Card on Progress and Challenges
Baker, T. B., & McCarthy, D. E. (2021) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-081219-090343 · Cited by 25
Schnoll, R. A., Martinez, E., Tatum, K. L., Glass, M., Bernath, A. M., Ferris, D. G., & Reynolds, P. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.11.001 · Cited by 19
Drugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment
Lee, A. M., & Tyndale, R. F. (2006) · Journal of Psychopharmacology · doi:10.1177/1359786806066039 · Cited by 19
Smoking Cessation 1: Pharmacological Treatments
Cofta-Woerpel, L. M., Wright, K. L., & Wetter, D. W. (2006) · Behavioral Medicine · doi:10.3200/bmed.32.2.47-56 · Cited by 19
Evaluation of a Mass Media Campaign Promoting Using Help to Quit Smoking
Gibson, L., Parvanta, S., Jeong, M., & Hornik, R. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.01.011 · Cited by 18
A Quantitative Estimate of the Clinical Significance of Treating Tobacco Dependence
Hughes, J. R. (2010) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.05.002 · Cited by 17
Self-citationPhysicians' counseling of patients when prescribing nicotine replacement therapy
Shiffman, S. M., Ferguson, S. G., & Hellebusch, S. J. (2006) · Addictive Behaviors · doi:10.1016/j.addbeh.2006.06.021 · Cited by 17
Self-citationCigarette abstinence impairs memory and metacognition despite administration of 2 mg nicotine gum.
Kelemen, W. L., & Fulton, E. K. (2008) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0014246 · Cited by 17
Smokers' expectancies for smoking versus nicotine.
Hendricks, P. S., & Brandon, T. H. (2008) · Psychology of Addictive Behaviors · doi:10.1037/0893-164x.22.1.135 · Cited by 16
The impact of nicotine replacement therapies on cigarette demand
Chaloupka, F. J., & Tauras, J. A. (2004) · Journal of Economics and Finance · doi:10.1007/bf02751741 · Cited by 15
Davis, K. A., Coady, M. H., Mbamalu, I. G., Sacks, R., & Kilgore, E. A. (2013) · Health Promotion Practice · doi:10.1177/1524839912471816 · Cited by 15
Electronic Cigarettes in Germany: Patterns of Use and Perceived Health Improvement
Lehmann, K., Kühn, S., & Reimer, J. (2017) · European Addiction Research · doi:10.1159/000475986 · Cited by 14
Does bupropion have advantages over other medical therapies in the cessation of smoking?
Tonstad, S., & Johnston, J. A. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.4.727 · Cited by 14
Therapeutic options and challenges for substances of abuse
Gardner, T. J., & Kosten, T. R. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.4/tgardner · Cited by 13
Nides, M. A., Danielsson, T., Saunders, F., Perfekt, R., Kapikian, R., Solla, J., Leischow, S. J., & Myers, A. (2018) · Nicotine & Tobacco Research · doi:10.1093/ntr/nty246 · Cited by 13
Overcoming barriers to disseminate effective smoking cessation treatments globally
Patwardhan, S., & Rose, J. E. (2020) · Drugs and Alcohol Today · doi:10.1108/dat-01-2020-0001 · Cited by 14
Fatores relacionados ao tabagismo e ao seu abandono
Cardoso, D. B., Coelho, A. P. C. P., Rodrigues, M., & Petroianu, A. (2010) · Revista de Medicina · doi:10.11606/issn.1679-9836.v89i2p76-82 · Cited by 12
Paudel, K. S., Wu, J., Hinds, B. J., & Stinchcomb, A. L. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23240 · Cited by 12
Bobak, A., Shiffman, S. S., Gitchell, J. G., Bery, J., & Ferguson, S. G. (2010) · The Journal of Smoking Cessation · doi:10.1375/jsc.5.2.115 · Cited by 12
Self-citationKurko, T., Linden, K., Vasama, M., Pietilä, K., & Airaksinen, M. S. A. (2009) · Health Policy · doi:10.1016/j.healthpol.2008.12.013 · Cited by 12
Richtlinien der Tabakentwöhnung Stand 2010
Lichtenschopf, A. (2011) · Wiener klinische Wochenschrift · doi:10.1007/s00508-011-1571-x · Cited by 10
Maximizing Smoking Cessation in Clinical Practice: Pharmacologic and Behavioral Interventions
Nides, M. A., Leischow, S. J., Sarna, L., & Evans, S. E. (2007) · Preventive Cardiology · doi:10.1111/j.1520-037x.2007.05992.x · Cited by 11
Review of the efficacy and safety of over-the-counter medicine
Possagno, G. C. H., Czepula, A. I. D. S., Otuki, M. F., & Correr, C. J. (2015) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502015000200018 · Cited by 10
Barrett, S. P., Campbell, M. L., Temporale, K. L., & Good, K. P. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1170 · Cited by 10
Westmaas, J. L., & Brandon, T. H. (2004) · Current Opinion in Pulmonary Medicine · doi:10.1097/01.mcp.0000128431.72268.4d · Cited by 10
Nicotine replacement therapy for smoking cessation in the "real world"
Shiffman, S. S. (2007) · Thorax · doi:10.1136/thx.2007.081919 · Cited by 9
Self-citationHayes, K. A., Jackson, C., Dickinson, D. M., & Miller, A. L. (2017) · American Journal of Health Promotion · doi:10.1177/0890117117723111 · Cited by 9
Withey, S. L., Doyle, M. R., Bergman, J., & Desai, R. I. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.248070 · Cited by 9
EFFECTIVENESS OF NICOTINE REPLACEMENT THERAPY—A REBUTTAL
Hughes, J. R., Cummings, K. M., Foulds, J., Shiffman, S. M., & West, R. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.03925.x · Cited by 8
Self-citationBarriers to electronic cigarette use
English, T. M., Smith, T. B., Song, X., & Whitman, M. V. (2018) · Public Health Nursing · doi:10.1111/phn.12406 · Cited by 8
Jackson, C., Hayes, K. A., & Dickinson, D. M. (2015) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntv214 · Cited by 7
Emerging drugs for the treatment of tobacco dependence
Ebbert, J. O. (2009) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210802623874 · Cited by 8
Naval Submarine Medical Research Laboratory
Roman, L. (2011) · Digital Commons @ Connecticut College (Connecticut College) · Cited by 8
The Effect of Nicotine Replacement Therapy Advertising on Youth Smoking
Saffer, H., Wakefield, M. A., & Terry‐McElrath, Y. M. (2007) · National Bureau of Economic Research · doi:10.3386/w12964 · Cited by 8
Transmucosal Delivery of Nicotine in Combination with Tincture of Benzoin Inhibits Apoptosis
Battaglia, A., & Nguyen, T. H. (2017) · Drugs in R&D · doi:10.1007/s40268-017-0212-x · Cited by 7
Tobacco Cessation: New Challenges, New Opportunities
Hopper, J. A., & Gallagher, R. (2003) · Journal of Cancer Education · doi:10.1207/s15430154jce1803_05 · Cited by 7
Implementation and evaluation of a smoking cessation group session program
Levshin, V. F., Radkevich, N., Slepchenko, N. I., & Droggachih, V. (2006) · Global Heart · doi:10.1016/j.precon.2006.05.003 · Cited by 7
Effect of deregulation on the prices of nicotine replacement therapy products in Finland
Aalto‐Setälä, V., & Alaranta, A. (2008) · Health Policy · doi:10.1016/j.healthpol.2007.11.013 · Cited by 6
The role of nicotine replacement therapy in early quitting success
Amodei, N., & Lamb, R. J. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp164 · Cited by 6
Chapman, S. F., & MacKenzie, R. (2012) · Public Health Ethics · doi:10.1093/phe/phr035 · Cited by 5
Baška, T., Straka, S., Bašková, M., & Maďar, R. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.3.487 · Cited by 5
Maine's Tobacco Medication Program: Compliance, patterns of use, and satisfaction among smokers
Tworek, C., Haskins, A. E., & Woods, S. S. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp085 · Cited by 5
Regulating Advertisements: The Case of Smoking Cessation Products
Avery, R. J., Kenkel, D., Lillard, D. R., & Mathios, A. (2006) · National Bureau of Economic Research · doi:10.3386/w12001 · Cited by 5
Analysis to support the Impact Assessment of the Commission's smoke-free initiatives
Watt, A., de Vries, H., Conklin, A., & Hatziandreu, E. (2009) · RAND Corporation eBooks · doi:10.7249/tr646 · Cited by 4
Wetherill, R. R., Spilka, N. H., Maron, M., Keyser, H., Jagannathan, K., Ely, A. V., & Franklin, T. R. (2021) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2021.100738 · Cited by 4
‘PAYMENT BY RESULTS’ AND SMOKING CESSATION SUPPORT
West, R. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03541.x · Cited by 4
Odukoya, O. O., Poluyi, E., Aina, B. A., Ejekam, C. S., & Faseru, B. (2016) · Tobacco Prevention & Cessation · doi:10.18332/tpc/61546 · Cited by 4
Varenicline Over-The-Counter Trial on Efficacy and Safety
Pearson, J., Nides, M. A., Cataldo, A., Martinez, M., Morales, J., Seltzer, R. G. N., Kurka, J. M., Broussard, M. L., & Leischow, S. J. (2024) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntae172 · Cited by 3
Willemsen, M. C. (2010) · Psychologie & gezondheid · doi:10.1007/bf03089365 · Cited by 3
Smoking Cessation: Significance and Implications for Children
Borchers, A. T., Keen, C. L., & Gershwin, M. E. (2007) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-007-8040-3 · Cited by 3
Kurko, T. (2015) · Työväentutkimus Vuosikirja · Cited by 3
Marcovitch, H. (2003) · BMJ · doi:10.1136/bmj.326.7397.1005 · Cited by 3
Electronic nicotine delivery systems for smoking cessation: where are we?
Schivo, M., Avdalovic, M. V., & Murin, S. (2014) · Current Respiratory Care Reports · doi:10.1007/s13665-014-0088-y · Cited by 2
Prevention, Information Technology, and Cancer
Morgan, G. D., & Fiore, M. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802115-6.00006-9 · Cited by 2
Authors respond to criticism that treatment is ineffective
Aveyard, P. N., Moore, D., Connock, M. J., Wang, D., Fry-Smith, A., & Barton, P. J. R. (2009) · BMJ · doi:10.1136/bmj.b1979 · Cited by 2
Fatores relacionados ao tabagismo e ao seu abandono Factors related to smoking and its interruption
Cardoso, D. B., Cota, P., Coelho, P., Rodrigues, M. G., & Petroianu, A. (2010) · Cited by 1
GABAergic Agents for the Treatment of Nicotine Dependence
Sofuoglu, M., & Lappalainen, J. (2006) · CRC Press eBooks · doi:10.1201/9781420005431.ch12 · Cited by 1
Verbesserte Produktmerkmale der Nikotinkaugummis
Mulzer, K.-H., Dando, S., GUSTAVSSON, G., Radley, N., Sjöstedt, G., Sydbom, P., & Waltermo, Å. (2011) · MMW - Fortschritte der Medizin · doi:10.1007/bf03372157 · Cited by 1
Lane, C. P., Graham, N. A., & Ovson, E. A. (2006) · Journal of Addictive Diseases · doi:10.1300/j069v25s01_03 · Cited by 1
Baclofen® as Anti-Craving Agent against Several Addiction
Keniche, A. (2017) · International Journal of Complementary & Alternative Medicine · doi:10.15406/ijcam.2017.09.00312 · Cited by 1
Pharmacological Therapeutics for Detoxification in Addictive Disorders
Kobeissy, F. H., Braga, C. F., Graham, N. A., & Gold, M. S. (2010) · Wiley eBooks · doi:10.1002/9780470710449.ch32 · Cited by 1
Interpreting odds ratios: examples from smoking cessation research
Walsh, R. A. (2004) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.2004.tb00449.x · Cited by 1
Accessibility of nicotine dependence therapy
Naboko, D., & Dimitrova, Z. (2007) · Journal of Public Health · doi:10.1007/s10389-007-0112-6 · Cited by 1
Talwar, A., Reichert, V. C., & Guntupalli, K. K. (2010) · Humana Press eBooks · doi:10.1007/978-1-59745-357-8_9 · Cited by 1
Antonuccio, D. O., & Mosier, J. M. (2006) · Springer eBooks · doi:10.1007/978-0-387-28370-8_66 · Cited by 2
Terapia farmacológica para el abandono del tabaquismo
Becerra, N., Cañón, M., & Vivas, J. M. (2010) · Universitas Médica · doi:10.11144/javeriana.umed51-2.tfpa
Combination of marketing strategies for increase of anti-smoking drugs sales
Naboko, D., Petkova, V. B., & Dimitrova, Z. (2008) · Journal of Medical Marketing Device Diagnostic and Pharmaceutical Marketing · doi:10.1057/palgrave.jmm.5050097
SUITSETAMISEST LOOBUMISE NÕUSTAMINE SA TÜK KOPSUKLIINIKUS 2006-2010
Mändla, T. (2012) · DSpace repository (University of Tartu)
cessation: a meta-analysis Nicotine replacement therapy for long-term smoking
Etter, J., & Stapleton, J. (2007)
Willemsen, M. C., & van Emst, A. J. (2008) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6554-8_6
PHARMACOTHERAPY OF SMOKING CESSATION: FOCUS ON VARENICLINE
Mason, K. (2006)
Wensaas, L. (2012) · NORA - Norwegian Open Research Archives
Characterization of Nicotine Replacement Therapy Use by Canadian Youths in Grades 9 – 12
Lane, N. E. (2011) · UWSpace (University of Waterloo)
David, S. P., McClure, J. B., & Swan, G. E. (2012) · Wiley eBooks · doi:10.1002/9781118133880.hop209007
Böning, J., Kienast, T., Heinz, A., Lesch, O., Soyka, M., Wiesbeck, G. A., Böning, J., Wodarz, N., Platz, W. E., Scherbaum, N., et al. (2007) · Springer eBooks · doi:10.1007/3-211-37774-3_4
Factors Influencing the Effectiveness of Mass Distribution of Free Nicotine Replacement Therapy
KUSHNIR, V. N. (2018) · TSpace (University of Toronto)
Making smokers different with nicotine: NRT and quitting
Keane, E. (2013)
Hoang, M. (2020) · TSpace (University of Toronto)
Chapman, S. F. (2007) · Wiley eBooks · doi:10.1002/9780470692479.refs
Zvolensky, M. J., Johnson, K., Yartz, A. R., & Leen‐Feldner, E. W. (2009) · Springer eBooks · doi:10.1007/978-0-387-09757-2_33
Medikamentöse Behandlung des Rauchers
Haustein, K.-O. (2008) · Springer eBooks · doi:10.1007/978-3-540-73309-6_13
Eriksen, M. P., & Whitney, C. F. (2013) · Oxford University Press eBooks · doi:10.1093/obo/9780199756797-0116
Metadata
- Authors
- Hughes, J. R., Shiffman, S., Callas, P., & Zhang, J.
- Affiliations
- University of Vermont (US)
- University of Pittsburgh (US)
- Corresponding author
- Hughes, J R
- ORCID
- Venue
- Tobacco Control
- Publisher
- BMJ
- Published
- 2003-03
- Volume
- 12
- Issue
- 1
- Pages
- 21-27
- ISSN
- 0964-4563 (ISSN-L)
- 1468-3318
- PMC
- PMC1759113
- OpenAlex
- W2135151757
- Cited by
- 203
- References
- 53
- Citations by year
- 2024: 2 · 2022: 1 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 6 · 2017: 7 · 2016: 7 · 2015: 6 · 2014: 8 · 2013: 11 · 2012: 11
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Tobacco Control (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Pittsburgh
- National Institute on Drug Abuse (DA00490)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Keywords
- nicotine gum, nicotine patch, smoking cessation, abstinence rates, drug efficacy
- MeSH terms
- Smoking Prevention, Nonprescription Drugs, Humans, Nicotine, Drug Prescriptions, Tobacco Use Disorder, Odds Ratio, Smoking Cessation, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review